-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OhLUPrUNRiOVB3t7YoC/6WKtq8iQjoUVUa9wDV0JUpjOYoO+j/NeuGG2iey3u9Br UiyhEmrTMmjxIYfQbX5bZA== 0001144204-04-006031.txt : 20040506 0001144204-04-006031.hdr.sgml : 20040506 20040506150658 ACCESSION NUMBER: 0001144204-04-006031 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040506 GROUP MEMBERS: ARIES DOMESTIC FUND II, LP GROUP MEMBERS: ARIES DOMESTIC FUND, L.P. GROUP MEMBERS: LINDSAY A. ROSENWALD GROUP MEMBERS: PARAMOUNG BIOCAPITAL ASSET MANAGEMENT, INC. GROUP MEMBERS: THE ARIES MASTER FUND II, LTD. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ARIES FINANCIAL SERVICES INC CENTRAL INDEX KEY: 0001007000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE STREET 2: SUITE 1501 CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128324379 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENTA INC DE/ CENTRAL INDEX KEY: 0000880643 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330326866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-42004 FILM NUMBER: 04784839 BUSINESS ADDRESS: STREET 1: TWO CONNELL DRIVE STREET 2: .. CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: (908) 286-9800 MAIL ADDRESS: STREET 1: TWO CONNELL DRIVE STREET 2: .. CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 SC 13D/A 1 v03069_sc13da.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDED SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 20)* GENTA INCORPORATED ------------------ (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE --------------------------------------- (Title of Class of Securities) 372 45 M 20 7 ------------- (CUSIP Number) Paramount BioCapital Asset Management, Inc. c/o Lindsay A. Rosenwald, M.D. 787 Seventh Avenue New York, NY 10019 (212) 554-4300 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) MAY 5, 2004 ----------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following: |_| Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 14 - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 2 of 14 Pages - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Paramount BioCapital Asset Management, Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) X - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER BENEFICIALLY OWNED BY None EACH REPORTING ----------------------------------------------------- PERSON 8 SHARED VOTING POWER WITH 4,306,532 ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER None ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 4,306,532 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,306,532 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.54% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 3 of 14 Pages - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Aries Domestic Fund, L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) X - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER BENEFICIALLY OWNED BY None EACH REPORTING ----------------------------------------------------- PERSON 8 SHARED VOTING POWER WITH 1,747,973 ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER None ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 1,747,973 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,747,973 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.3% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 4 of 14 Pages - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Aries Domestic Fund II, LP - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) X - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER BENEFICIALLY OWNED BY None EACH REPORTING ----------------------------------------------------- PERSON 8 SHARED VOTING POWER WITH 184,866 ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER None ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 184,866 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 184,866 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.2% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 5 of 14 Pages - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON The Aries Master Fund II, Ltd. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) X - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER BENEFICIALLY OWNED BY None EACH REPORTING ----------------------------------------------------- PERSON 8 SHARED VOTING POWER WITH 2,373,693 ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER None ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 2,373,693 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,373,693 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.0% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* OO (see Item 2) - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- CUSIP No. 372 45 M 20 7 13D Page 6 of 14 Pages - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Lindsay A. Rosenwald - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) X - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* OO (see Item 3) - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER BENEFICIALLY OWNED BY 3,330,522 EACH REPORTING ----------------------------------------------------- PERSON 8 SHARED VOTING POWER WITH 4,306,532 ----------------------------------------------------- 9 SOLE DISPOSITIVE POWER 3,330,522 ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 4,306,532 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,637,054 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.4% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* OO (see Item 2) - -------------------------------------------------------------------------------- This Amendment No. 20 amends and supplements the following items of the Statement on Schedule 13D filed by certain of the reporting persons, dated February 24, 1997, as amended to date (the "Schedule"). ITEM 2. IDENTITY AND BACKGROUND Item 2 is hereby amended in its entirety to read as follows: (a) This statement is filed on behalf of Paramount BioCapital Asset Management, Inc. ("PCAM"), Aries Select, Ltd. ("Aries Select"), Aries Select, LLC ("AS1") and Dr. Lindsay A. Rosenwald (together with PCAM and Aries Select the "Aries Reporting Persons"), Aries Select II, LLC ("AS2"), Aries Domestic Fund, L.P. ("ADF1"), The Aries Master Fund II, a Cayman Island exempted company ("AMF2"), and Aries Domestic Fund II, L.P. ("ADF2" and, together with the Aries Reporting Persons, the "Filing Persons"). See attached Exhibit A which is a copy of their agreement in writing to file this statement jointly on behalf of each of them. The Filing Persons have made, and will continue to make, their own investment decisions. (b) The business address of Dr. Rosenwald, PCAM, Aries Select, AS1, AS2, Aries Domestic and Aries Domestic II is 787 Seventh Avenue, 48th Floor, New York, New York 10019. The business address for Aries Select and AMF2 is c/o Fortis Fund Services, P.O. Box 2003, British American Centre, Phase 3, Dr. Roy's Drive, George Town, Grand Cayman. (c) Dr. Rosenwald is an investment banker, venture capitalist, fund manager and sole shareholder of PCAM,1 a Subchapter S corporation incorporated in the State of Delaware. PCAM is the managing member of each of AS1 and AS2, the General Partner of Aries Domestic and Aries Domestic II, each a limited partnership organized under the laws of Delaware and the investment manager to AMF2 and Aries Select2, each a Cayman Island exempted company. (d) The Filing Persons and their respective officers, directors, general partners, investment managers, and trustees have not, during the five years prior to the date hereof, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) The Filing Persons and their respective officers, directors, general partners, investment managers, and trustees have not been, during the five years prior to the date hereof, parties to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or funding any violation with respect to such laws. (f) Dr. Rosenwald is a citizen of the United States. - ----------------------- 1 Please see Exhibit B, filed herewith, indicating the executive officers and directors of PCAM and providing information called for by Items 2-6 of this statement as to said officers and directors. 2 Please see Exhibit C indicating the executive officers and directors of AMF2 and Aries Select and providing information called for by Items 2-6 of this statement as to said officers and directors. Page 7 of 14 ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION The information contained in Item 3 to the Schedule is hereby amended by adding the following: On May 3, 2004, pursuant to Rule 144 (a) AMF2 sold 1,501,900 Shares of the Issuer at a price equal to $5.05 for aggregate gross proceeds equal to $7,584,595, (b) ADF sold 1,128,700 shares of the Issuer at a price equal to $5.05 for aggregate gross proceeds equal to $5,699,935 and (c) ADF2 sold 119,400 Shares of the Issuer at a price equal to $5.05 for aggregate gross proceeds equal to $602,970. On May 4, 2004, pursuant to Rule 144 (a) AMF2 sold 3,446,300 Shares of the Issuer at a price equal to $4.92 for aggregate gross proceeds equal to $16,955,796.00, (b) ADF sold 2,589,800 shares of the Issuer at a price equal to $4.92 for aggregate gross proceeds equal to $12,741,816.00 and (c) ADF2 sold 273,900 Shares of the Issuer at a price equal to $5.05 for aggregate gross proceeds equal to $1,170,468. On May 5, 2004, pursuant to Rule 144 (a) AMF2 sold 513,400 Shares of the Issuer at a price equal to $4.95 for aggregate gross proceeds equal to $2,541,330, (b) ADF sold 385,800 shares of the Issuer at a price equal to $4.95 for aggregate gross proceeds equal to $1,909,710 and (c) ADF2 sold 40,800 Shares of the Issuer at a price equal to $4.95 for aggregate gross proceeds equal to $201,960. ITEM 4. PURPOSE OF THE TRANSACTION. On May 3, 2004, May 4, 2004 and May 5, 2004, the Reporting Persons substantially reduced its ownership position in the Issuer. The Reporting Persons currently hold the securities reported herein as being beneficially owned by them for investment purposes. Depending upon market conditions and other factors that the Reporting Persons may deem material to their respective investment decisions, the Reporting Persons may purchase additional securities of the Company in the open market or in private transactions, or may dispose of all or a portion of the securities of the Company that the Reporting Persons own or hereafter may acquire. Except as otherwise set forth herein, none of the persons or entities named in Item 2 has any plans or proposals which relate to, or could result, in any of the matters referred to in Paragraphs (b) through (j) of Item 4 of Schedule 13D. The Filing Persons may formulate other purposes, plans or proposals relating to any of such securities of the Issuer to the extent deemed advisable in light of market conditions, investment policies and other factors. Page 8 of 14 ITEM 5. INTEREST IN SECURITIES OF ISSUER. The information contained in Item 5 to the Schedule is hereby amended and supplemented to read as follows: (a) As of May 5, 2004, the Filing Persons may be deemed to beneficially own the following: (i) ARIES SELECT: 0 Shares (0%); (ii) AS1: 0 Shares (0%); (iii) AS2: 0 Shares (0%); (iv) AMF2: 2,373,693 Shares (3.0%); (v) ARIES DOMESTIC: 1,747,973 Shares (2.3%); (vi) ARIES DOMESTIC II: 184,866 Shares (0.2%); (vii) PCAM: 4,306,532 Shares (5.5%), comprised of the Shares held by AMF2, Aries Domestic and Aries Domestic II; and (viii) DR. ROSENWALD: 7,637,054 Shares (9.4%), comprised of 25,000 Shares and 3,305,522 Shares issuable upon exercise of Common Stock purchase warrants held directly by Dr. Rosenwald and 4,306,532 Shares beneficially owned by PCAM. Pursuant to Rule 13d-4 promulgated under the Securities Exchange Act of 1934, as amended, each Filing Person other than Dr. Rosenwald disclaims beneficial ownership of the securities held by each other. (b) Dr. Rosenwald and PCAM share the power to vote or to direct the vote and to dispose or to direct the disposition of those shares owned by each of AMF2, Aries Domestic and Aries Domestic II. (c) The Filing Persons have engaged in the following transactions in the Common Stock of the Issuer in the past 60 days: On April 22, 2004 AMF2, Aries Domestic and Aries Domestic II distributed 6,267, 43,673 and 37,225 Shares, respectively to certain redeeming investors and on April 27, 2004 AMF2 and Aries Domestic distributed 159,741 and 1,107 Shares, respectively to certain redeeming investors. Please see Item 3 for additional transactions (d) Dr. Rosenwald, as the sole shareholder of PCAM, has the right to participate in the receipt of dividends from, or proceeds from the sale of, Shares held by PCAM in accordance with his ownership interests in PCAM. (e) N/A. Item 7. MATERIAL TO BE FILED AS EXHIBITS: Exhibit A - Copy of an Agreement between the Filing Persons to file this Statement on Schedule 13D on behalf of each of them. Exhibit B - List of executive officers and directors of PCAM and information called for by Items 2-6 of this statement relating to said officers and directors. Exhibit C - List of executive officers and directors of AMF2 Aries Select and information called for by Items 2-6 of this statement relating to said officers and directors. Page 9 of 14 SIGNATURES After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certify that the information set forth in this statement is true, complete and correct. PARAMOUNT BIOCAPITAL ASSET MANAGEMENT, INC. Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman THE ARIES MASTER FUND By: Paramount BioCapital Asset Management, Inc. Investment Manager Dated: May 6, 2004 New York, NY By: ______________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND, L.P. By: Paramount BioCapital Asset Management, Inc. General Partner Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND II, L.P. By: Paramount BioCapital Asset Management, Inc. General Partner Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES SELECT, LTD. By: Paramount BioCapital Asset Management, Inc. Investment Manager Dated: May 6, 2004 New York, NY By: ______________________________ Lindsay A. Rosenwald, M.D. Chairman Page 10 of 14 ARIES SELECT DOMESTIC, LLC By: Paramount BioCapital Asset Management, Inc. Managing Member Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES SELECT DOMESTIC II, LLC By: Paramount BioCapital Asset Management, Inc. Managing Member Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman Dated: May 6, 2004 New York, NY _________________________________ Lindsay A. Rosenwald, M.D. Page 11 of 14 EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13D The undersigned hereby agree jointly to prepare and file with regulatory authorities a Schedule 13D and any amendments thereto reporting each of the undersigned's ownership of securities of Genta Incorporated and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned. PARAMOUNT BIOCAPITAL ASSET MANAGEMENT, INC. Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman THE ARIES MASTER FUND By: Paramount BioCapital Asset Management, Inc. Investment Manager Dated: May 6, 2004 New York, NY By: ______________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND, L.P. By: Paramount BioCapital Asset Management, Inc. General Partner Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES DOMESTIC FUND II, L.P. By: Paramount BioCapital Asset Management, Inc. General Partner Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES SELECT, LTD. By: Paramount BioCapital Asset Management, Inc. Investment Manager Dated: May 6, 2004 New York, NY By: ______________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES SELECT DOMESTIC, LLC By: Paramount BioCapital Asset Management, Inc. Managing Member Dated: May 6, 2004 New York, NY By: ________________________________ Lindsay A. Rosenwald, M.D. Chairman ARIES SELECT DOMESTIC II, LLC By: Paramount BioCapital Asset Management, Inc. Managing Member Dated: May 6, 2004 New York, NY By: ________________________________ A. Rosenwald, M.D. Chairman Dated: May 6, 2004 New York, NY _________________________________ Lindsay A. Rosenwald, M.D. Page 12 of 14 EXHIBIT B The name and principal occupation or employment of each executive officer and director of Paramount BioCapital is as follows: PRINCIPAL OCCUPATION NAME OR EMPLOYMENT ---- ------------- Lindsay A. Rosenwald, M.D. Chairman of the Board of Paramount BioCapital Asset Management, Inc., Horizon BioMedical Investments, LLC and Paramount BioCapital, Inc. Peter Morgan Kash Director of Paramount BioCapital Asset Management, Inc., Senior Managing Director, Paramount BioCapital, Inc. Dr. Yuichi Iwaki Director of Paramount BioCapital Asset Management, Inc., Professor, University of Southern California School of Medicine Item 2. During the five years prior to the date hereof, none of the above persons (to the best of PCAM's knowledge) was convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws. Items 3-6. Please refer to Items 3-6 herein reporting the beneficial ownership. Page 13 of 14 EXHIBIT C The name and principal occupation or employment of each executive officer and director of Aries Trust is as follows: PRINCIPAL OCCUPATION NAME OR EMPLOYMENT ---- ------------- Peter M. Kash Director of Paramount BioCapital Asset Management, Inc., Senior Managing Director, Paramount BioCapital, Inc. Investment Manager Wayne L. Rubin Accountant, Independent Director Fortis Fund Services (Cayman) Administrator Exhibit B is hereby incorporated by reference. Item 2. During the five years prior to the date hereof, neither of the above persons (to the best of Aries Select's knowledge) have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws. Items 3-6. Please refer to Items 3-6 herein reporting the beneficial ownership. Page 14 of 14 -----END PRIVACY-ENHANCED MESSAGE-----